+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Regenerative Medicine Market in Japan 2023-2027

  • PDF Icon

    Report

  • 127 Pages
  • September 2023
  • Region: Japan
  • TechNavio
  • ID: 5880852
1h Free Analyst Time
Description Jump to:

Increasing Number of Clinical Trials is a Key Trend Gaining Market Momentum

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The regenerative medicine market in Japan is forecasted to grow by USD 2.32 billion during 2022-2027, accelerating at a CAGR of 15.89% during the forecast period. The market is driven by increasing adoption of stem cell therapy, favorable government regulations for regenerative medicine, and an increasing aging population.

This report on the regenerative medicine market in Japan provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.

The regenerative medicine market in Japan is segmented as below:

By Application

  • Oncology
  • Musculoskeletal
  • Dermatology
  • Immunology and Inflammation and others

By Technology

  • Cell and tissue-based
  • Gene therapy
This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicine market in Japan growth during the next few years. Also, growing mergers and acquisitions by market vendors and the development of induced pluripotent stem cells will lead to sizable demand in the market.

The report on the regenerative medicine market in Japan covers the following areas:

  • Regenerative medicine market in Japan sizing
  • Regenerative medicine market in Japan forecast
  • Regenerative medicine market in Japan industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicine market in Japan vendors that include Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Corp., HEALIOS K.K., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., MEDINET Co. Ltd., Metcela Inc., Nikon Corp., ROHTO Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp.. Also, the regenerative medicine market in Japan analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Country Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibit 06: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Exhibit 07: Parent market
  • Exhibit 08: Market Characteristics
3 Market Sizing
3.1 Market definition
  • Exhibit 09: Offerings of vendors included in the market definition
3.2 Market segment analysis
  • Exhibit 10: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 11: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 12: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 13: Chart on Japan: Year-over-year growth 2022-2027 (%)
  • Exhibit 14: Data Table on Japan: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Regenerative medicine market in Japan 2017 - 2021
  • Exhibit 15: Historic Market Size - Data Table on regenerative medicine market in Japan 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
  • Exhibit 16: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 Technology Segment Analysis 2017 - 2021
  • Exhibit 17: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
  • Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
  • Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
  • Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
  • Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
  • Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
  • Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
6.1 Market segments
  • Exhibit 25: Chart on Application - Market share 2022-2027 (%)
  • Exhibit 26: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
  • Exhibit 27: Chart on Comparison by Application
  • Exhibit 28: Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2022-2027
  • Exhibit 29: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
  • Exhibit 30: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
  • Exhibit 31: Chart on Oncology - Year-over-year growth 2022-2027 (%)
  • Exhibit 32: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
6.4 Musculoskeletal - Market size and forecast 2022-2027
  • Exhibit 33: Chart on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
  • Exhibit 34: Data Table on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Chart on Musculoskeletal - Year-over-year growth 2022-2027 (%)
  • Exhibit 36: Data Table on Musculoskeletal - Year-over-year growth 2022-2027 (%)
6.5 Dermatology - Market size and forecast 2022-2027
  • Exhibit 37: Chart on Dermatology - Market size and forecast 2022-2027 ($ million)
  • Exhibit 38: Data Table on Dermatology - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Chart on Dermatology - Year-over-year growth 2022-2027 (%)
  • Exhibit 40: Data Table on Dermatology - Year-over-year growth 2022-2027 (%)
6.6 Immunology and Inflammation and others - Market size and forecast 2022-2027
  • Exhibit 41: Chart on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 42: Data Table on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Chart on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)
  • Exhibit 44: Data Table on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Application
  • Exhibit 45: Market opportunity by Application ($ million)
  • Exhibit 46: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Technology
7.1 Market segments
  • Exhibit 47: Chart on Technology - Market share 2022-2027 (%)
  • Exhibit 48: Data Table on Technology - Market share 2022-2027 (%)
7.2 Comparison by Technology
  • Exhibit 49: Chart on Comparison by Technology
  • Exhibit 50: Data Table on Comparison by Technology
7.3 Cell and tissue-based - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Data Table on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Chart on Cell and tissue-based - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Cell and tissue-based - Year-over-year growth 2022-2027 (%)
7.4 Gene therapy - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Gene therapy - Market size and forecast 2022-2027 ($ million)
  • Exhibit 56: Data Table on Gene therapy - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Chart on Gene therapy - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Gene therapy - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Technology
  • Exhibit 59: Market opportunity by Technology ($ million)
  • Exhibit 60: Data Table on Market opportunity by Technology ($ million)
8 Customer Landscape
8.1 Customer landscape overview
  • Exhibit 61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
  • Exhibit 62: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends
10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
  • Exhibit 63: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
  • Exhibit 64: Overview on factors of disruption
10.4 Industry risks
  • Exhibit 65: Impact of key risks on business
11 Vendor Analysis
11.1 Vendors covered
  • Exhibit 66: Vendors covered
11.2 Market positioning of vendors
  • Exhibit 67: Matrix on vendor position and classification
11.3 Astellas Pharma Inc.
  • Exhibit 68: Astellas Pharma Inc. - Overview
  • Exhibit 69: Astellas Pharma Inc. - Product / Service
  • Exhibit 70: Astellas Pharma Inc. - Key news
  • Exhibit 71: Astellas Pharma Inc. - Key offerings
11.4 Becton Dickinson and Co.
  • Exhibit 72: Becton Dickinson and Co. - Overview
  • Exhibit 73: Becton Dickinson and Co. - Business segments
  • Exhibit 74: Becton Dickinson and Co. - Key news
  • Exhibit 75: Becton Dickinson and Co. - Key offerings
  • Exhibit 76: Becton Dickinson and Co. - Segment focus
11.5 CellSeed Inc.
  • Exhibit 77: CellSeed Inc. - Overview
  • Exhibit 78: CellSeed Inc. - Product / Service
  • Exhibit 79: CellSeed Inc. - Key offerings
11.6 Cyfuse Biomedical K.K.
  • Exhibit 80: Cyfuse Biomedical K.K. - Overview
  • Exhibit 81: Cyfuse Biomedical K.K. - Product / Service
  • Exhibit 82: Cyfuse Biomedical K.K. - Key offerings
11.7 F. Hoffmann La Roche Ltd.
  • Exhibit 83: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 84: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 85: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 86: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 87: F. Hoffmann La Roche Ltd. - Segment focus
11.8 FUJIFILM Corp.
  • Exhibit 88: FUJIFILM Corp. - Overview
  • Exhibit 89: FUJIFILM Corp. - Business segments
  • Exhibit 90: FUJIFILM Corp. - Key news
  • Exhibit 91: FUJIFILM Corp. - Key offerings
  • Exhibit 92: FUJIFILM Corp. - Segment focus
11.9 iHeart Japan Corp.
  • Exhibit 93: iHeart Japan Corp. - Overview
  • Exhibit 94: iHeart Japan Corp. - Product / Service
  • Exhibit 95: iHeart Japan Corp. - Key offerings
11.10 JCR Pharmaceticals Co. Ltd.
  • Exhibit 96: JCR Pharmaceticals Co. Ltd. - Overview
  • Exhibit 97: JCR Pharmaceticals Co. Ltd. - Product / Service
  • Exhibit 98: JCR Pharmaceticals Co. Ltd. - Key offerings
11.11 Nikon Corp.
  • Exhibit 99: Nikon Corp. - Overview
  • Exhibit 100: Nikon Corp. - Business segments
  • Exhibit 101: Nikon Corp. - Key news
  • Exhibit 102: Nikon Corp. - Key offerings
  • Exhibit 103: Nikon Corp. - Segment focus
11.12 ROHTO Pharmaceutical Co. Ltd.
  • Exhibit 104: ROHTO Pharmaceutical Co. Ltd. - Overview
  • Exhibit 105: ROHTO Pharmaceutical Co. Ltd. - Business segments
  • Exhibit 106: ROHTO Pharmaceutical Co. Ltd. - Key offerings
  • Exhibit 107: ROHTO Pharmaceutical Co. Ltd. - Segment focus
11.13 Sumitomo Pharma Co. Ltd.
  • Exhibit 108: Sumitomo Pharma Co. Ltd. - Overview
  • Exhibit 109: Sumitomo Pharma Co. Ltd. - Business segments
  • Exhibit 110: Sumitomo Pharma Co. Ltd. - Key offerings
  • Exhibit 111: Sumitomo Pharma Co. Ltd. - Segment focus
11.14 Takara Bio Inc.
  • Exhibit 112: Takara Bio Inc. - Overview
  • Exhibit 113: Takara Bio Inc. - Product / Service
  • Exhibit 114: Takara Bio Inc. - Key offerings
11.15 Takeda Pharmaceutical Co. Ltd.
  • Exhibit 115: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibit 116: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Key offerings
11.16 Terumo Corp.
  • Exhibit 119: Terumo Corp. - Overview
  • Exhibit 120: Terumo Corp. - Business segments
  • Exhibit 121: Terumo Corp. - Key news
  • Exhibit 122: Terumo Corp. - Key offerings
  • Exhibit 123: Terumo Corp. - Segment focus
11.17 Yokogawa Electric Corp.
  • Exhibit 124: Yokogawa Electric Corp. - Overview
  • Exhibit 125: Yokogawa Electric Corp. - Business segments
  • Exhibit 126: Yokogawa Electric Corp. - Key offerings
  • Exhibit 127: Yokogawa Electric Corp. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
  • Exhibit 128: Inclusions checklist
  • Exhibit 129: Exclusions checklist
12.3 Currency conversion rates for US$
  • Exhibit 130: Currency conversion rates for US$
12.4 Research methodology
  • Exhibit 131: Research methodology
  • Exhibit 132: Validation techniques employed for market sizing
  • Exhibit 133: Information sources
12.5 List of abbreviations
  • Exhibit 134: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Country Market Characteristics
Exhibit 4: Executive Summary - Chart on Market Segmentation by Application
Exhibit 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 6: Executive Summary - Chart on Vendor Market Positioning
Exhibit 7: Parent market
Exhibit 8: Market Characteristics
Exhibit 9: Offerings of vendors included in the market definition
Exhibit 10: Market segments
Exhibit 11: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 12: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 13: Chart on Japan: Year-over-year growth 2022-2027 (%)
Exhibit 14: Data Table on Japan: Year-over-year growth 2022-2027 (%)
Exhibit 15: Historic Market Size - Data Table on regenerative medicine market in Japan 2017 - 2021 ($ million)
Exhibit 16: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibit 17: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
Exhibit 25: Chart on Application - Market share 2022-2027 (%)
Exhibit 26: Data Table on Application - Market share 2022-2027 (%)
Exhibit 27: Chart on Comparison by Application
Exhibit 28: Data Table on Comparison by Application
Exhibit 29: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 30: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 31: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 32: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 33: Chart on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibit 34: Data Table on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Chart on Musculoskeletal - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Musculoskeletal - Year-over-year growth 2022-2027 (%)
Exhibit 37: Chart on Dermatology - Market size and forecast 2022-2027 ($ million)
Exhibit 38: Data Table on Dermatology - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Chart on Dermatology - Year-over-year growth 2022-2027 (%)
Exhibit 40: Data Table on Dermatology - Year-over-year growth 2022-2027 (%)
Exhibit 41: Chart on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
Exhibit 42: Data Table on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Chart on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)
Exhibit 44: Data Table on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Market opportunity by Application ($ million)
Exhibit 46: Data Table on Market opportunity by Application ($ million)
Exhibit 47: Chart on Technology - Market share 2022-2027 (%)
Exhibit 48: Data Table on Technology - Market share 2022-2027 (%)
Exhibit 49: Chart on Comparison by Technology
Exhibit 50: Data Table on Comparison by Technology
Exhibit 51: Chart on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Cell and tissue-based - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Cell and tissue-based - Year-over-year growth 2022-2027 (%)
Exhibit 55: Chart on Gene therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Gene therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Gene therapy - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Gene therapy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Market opportunity by Technology ($ million)
Exhibit 60: Data Table on Market opportunity by Technology ($ million)
Exhibit 61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 62: Impact of drivers and challenges in 2022 and 2027
Exhibit 63: Overview on Criticality of inputs and Factors of differentiation
Exhibit 64: Overview on factors of disruption
Exhibit 65: Impact of key risks on business
Exhibit 66: Vendors covered
Exhibit 67: Matrix on vendor position and classification
Exhibit 68: Astellas Pharma Inc. - Overview
Exhibit 69: Astellas Pharma Inc. - Product / Service
Exhibit 70: Astellas Pharma Inc. - Key news
Exhibit 71: Astellas Pharma Inc. - Key offerings
Exhibit 72: Becton Dickinson and Co. - Overview
Exhibit 73: Becton Dickinson and Co. - Business segments
Exhibit 74: Becton Dickinson and Co. - Key news
Exhibit 75: Becton Dickinson and Co. - Key offerings
Exhibit 76: Becton Dickinson and Co. - Segment focus
Exhibit 77: CellSeed Inc. - Overview
Exhibit 78: CellSeed Inc. - Product / Service
Exhibit 79: CellSeed Inc. - Key offerings
Exhibit 80: Cyfuse Biomedical K.K. - Overview
Exhibit 81: Cyfuse Biomedical K.K. - Product / Service
Exhibit 82: Cyfuse Biomedical K.K. - Key offerings
Exhibit 83: F. Hoffmann La Roche Ltd. - Overview
Exhibit 84: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 85: F. Hoffmann La Roche Ltd. - Key news
Exhibit 86: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 87: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 88: FUJIFILM Corp. - Overview
Exhibit 89: FUJIFILM Corp. - Business segments
Exhibit 90: FUJIFILM Corp. - Key news
Exhibit 91: FUJIFILM Corp. - Key offerings
Exhibit 92: FUJIFILM Corp. - Segment focus
Exhibit 93: iHeart Japan Corp. - Overview
Exhibit 94: iHeart Japan Corp. - Product / Service
Exhibit 95: iHeart Japan Corp. - Key offerings
Exhibit 96: JCR Pharmaceticals Co. Ltd. - Overview
Exhibit 97: JCR Pharmaceticals Co. Ltd. - Product / Service
Exhibit 98: JCR Pharmaceticals Co. Ltd. - Key offerings
Exhibit 99: Nikon Corp. - Overview
Exhibit 100: Nikon Corp. - Business segments
Exhibit 101: Nikon Corp. - Key news
Exhibit 102: Nikon Corp. - Key offerings
Exhibit 103: Nikon Corp. - Segment focus
Exhibit 104: ROHTO Pharmaceutical Co. Ltd. - Overview
Exhibit 105: ROHTO Pharmaceutical Co. Ltd. - Business segments
Exhibit 106: ROHTO Pharmaceutical Co. Ltd. - Key offerings
Exhibit 107: ROHTO Pharmaceutical Co. Ltd. - Segment focus
Exhibit 108: Sumitomo Pharma Co. Ltd. - Overview
Exhibit 109: Sumitomo Pharma Co. Ltd. - Business segments
Exhibit 110: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibit 111: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibit 112: Takara Bio Inc. - Overview
Exhibit 113: Takara Bio Inc. - Product / Service
Exhibit 114: Takara Bio Inc. - Key offerings
Exhibit 115: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 116: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibit 119: Terumo Corp. - Overview
Exhibit 120: Terumo Corp. - Business segments
Exhibit 121: Terumo Corp. - Key news
Exhibit 122: Terumo Corp. - Key offerings
Exhibit 123: Terumo Corp. - Segment focus
Exhibit 124: Yokogawa Electric Corp. - Overview
Exhibit 125: Yokogawa Electric Corp. - Business segments
Exhibit 126: Yokogawa Electric Corp. - Key offerings
Exhibit 127: Yokogawa Electric Corp. - Segment focus
Exhibit 128: Inclusions checklist
Exhibit 129: Exclusions checklist
Exhibit 130: Currency conversion rates for US$
Exhibit 131: Research methodology
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
Exhibit 134: List of abbreviations

Executive Summary

The research team recognizes the following companies as the key players in the global regenerative medicine market in Japan: Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Corp., HEALIOS K.K., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., MEDINET Co. Ltd., Metcela Inc., Nikon Corp., ROHTO Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp.

One of the report's analysts commented on the report, saying: 'The latest trend gaining momentum in the market is increasing number of clinical trials.'

According to the report, one of the major drivers for this market is the increasing adoption of stem cell therapy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Astellas Pharma Inc.
  • Becton Dickinson and Co.
  • CellSeed Inc.
  • Cellusion Inc.
  • Cyfuse Biomedical K.K.
  • F. Hoffmann La Roche Ltd.
  • FUJIFILM Corp.
  • HEALIOS K.K.
  • iHeart Japan Corp.
  • Japan Tissue Engineering Co. Ltd.
  • JCR Pharmaceticals Co. Ltd.
  • MEDINET Co. Ltd.
  • Metcela Inc.
  • Nikon Corp.
  • ROHTO Pharmaceutical Co. Ltd.
  • Sumitomo Pharma Co. Ltd.
  • Takara Bio Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Terumo Corp.
  • Yokogawa Electric Corp.

Related Topics

Related Reports

Global Regenerative Medicine Market 2024-2028 - Product Image

Global Regenerative Medicine Market 2024-2028

  • Report
  • 178 Pages
  • Global
From
Global Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Forecast 2024-2030 - Product Image

Global Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) - Forecast to 2028 - Product Image

Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) - Forecast to 2028

  • Report
  • 293 Pages
  • Global
From
Translational Regenerative Medicine Market Report 2024-2034 - Product Image

Translational Regenerative Medicine Market Report 2024-2034

  • Report
  • 270 Pages
  • Global
From
Regenerative Medicine Collaboration and Licensing Deals 2016-2024 - Product Image

Regenerative Medicine Collaboration and Licensing Deals 2016-2024

  • Report
  • 1050 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.